Though it's still struggling with data integration, Detroit's Henry Ford Health System is standardizing workflows and beginning to measure outcomes.
Precision cancer company Syapse is teaming with Seoul National University Hospital and Asian AWS partner Megazone
Pharmaceutical giant Roche has entered into a collaboration with Syapse to widen access to precision oncology technology and services.
Syapse has raised new venture capital to support expansion into community hospitals that want to start precision oncology programs.
Through the deal, Sylvester will have access to Syapse's precision medicine platform for cancer care.
The agreement lets Biotheranostics offer its CancerType ID and Breast Cancer Index genomic tests to customers through Syapse's software.
The two health systems have also joined the OPeN consortium and plan to share cancer patient data in support of the Cancer Moonshot Initiative.
Within the consortium community healthcare systems can contribute and access each other's data on cancer patients' molecular profiles and treatment outcomes.
The consortium aims to share aggregated data between its members, enabling more cancer patients to benefit from high volume-based analytics.
With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.
NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.
CNBC reports that there are thousands of genetic tests available for consumers to chose between.
In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.